Common Contracts

EX-10.2 3 a15-6181_1ex10d2.htm EX-10.2 CONFIDENTIAL TREATMENT REQUESTED ROYALTY PURCHASE AGREEMENT dated as of March 24, 2015 between IMMUNOGEN, INC., HURRICANE, LLC as Seller and IMMUNITY ROYALTY HOLDINGS, L.P.

Royalty Purchase Agreement • May 5th, 2020 • New York

• Contract Type
  Royalty Purchase Agreement
• Filed
  May 5th, 2020
• Jurisdiction
  New York

Portions of the exhibit, indicated by the mark “[***],” were omitted and have been filed separately with the Securities and Exchange Commission pursuant to the Registrant’s application requesting confidential treatment pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

CONFIDENTIAL TREATMENT REQUESTED ROYALTY PURCHASE AGREEMENT dated as of March 24, 2015 between IMMUNOGEN, INC., HURRICANE, LLC as Seller and IMMUNITY ROYALTY HOLDINGS, L.P. Portions of the exhibit, indicated by the mark “[***],” were omitted and have...

Royalty Purchase Agreement • May 8th, 2015 • Immunogen Inc • Pharmaceutical preparations • New York

• Contract Type
  Royalty Purchase Agreement
• Filed
  May 8th, 2015
• Company
  Immunogen Inc
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

ROYALTY PURCHASE AGREEMENT (as amended, supplemented or otherwise modified from time to time, this “Agreement”) is made and entered into as of March 24, 2015 (referred to herein as “the date of this Agreement”), by and among ImmunoGen, Inc., a Massachusetts corporation (“ImmunoGen”), Hurricane, LLC, a Massachusetts limited liability company (the “Seller,” and together with ImmunoGen, the “Selling Parties”) and Immunity Royalty Holdings, L.P., a Delaware limited partnership (the “Purchaser”).